» Articles » PMID: 38458330

The Role of Telomerase Reverse Transcriptase in the Mitochondrial Protective Functions of Angiotensin-(1-7) in Diabetic CD34 Cells

Overview
Date 2024 Mar 8
PMID 38458330
Authors
Affiliations
Soon will be listed here.
Abstract

Angiotensin (Ang)-(1-7) stimulates vasoprotective functions of diabetic (DB) CD34 hematopoietic stem/progenitor cells partly by decreasing reactive oxygen species (ROS), increasing nitric oxide (NO) levels and decreasing TGFβ1 secretion. Telomerase reverse transcriptase (TERT) translocates to mitochondria and regulates ROS generation. Alternative splicing of TERT results in variants α-, β- and α-β-TERT, which may oppose functions of full-length (FL) TERT. This study tested if the protective functions of Ang-(1-7) or TGFβ1-silencing are mediated by mitoTERT and that diabetes decreases FL-TERT expression by inducing splicing. CD34 cells were isolated from the peripheral blood mononuclear cells of nondiabetic (ND, n = 68) or DB (n = 74) subjects. NO and mitoROS levels were evaluated by flow cytometry. TERT splice variants and mitoDNA-lesions were characterized by qPCR. TRAP assay was used for telomerase activity. Decoy peptide was used to block mitochondrial translocation (mitoXTERT). TERT inhibitor or mitoXTERT prevented the effects of Ang-(1-7) on NO or mitoROS levels in DB-CD34 cells. FL-TERT expression and telomerase activity were lower and mitoDNA-lesions were higher in DB cells compared to ND and were reversed by Ang-(1-7) or TGFβ1-silencing. The prevalence of TERT splice variants, with predominant β-TERT expression, was higher and the expression of FL-TERT was lower in DB cells (n = 25) compared to ND (n = 30). Ang-(1-7) or TGFβ1-silencing decreased TERT-splicing and increased FL-TERT. Blocking of β-splicing increased FL-TERT and protected mitoDNA in DB-cells. The findings suggest that diabetes induces TERT-splicing in CD34 cells and that β-TERT splice variant largely contributes to the mitoDNA oxidative damage.

References
1.
Kim W, Ludlow A, Min J, Robin J, Stadler G, Mender I . Regulation of the Human Telomerase Gene TERT by Telomere Position Effect-Over Long Distances (TPE-OLD): Implications for Aging and Cancer. PLoS Biol. 2016; 14(12):e2000016. PMC: 5169358. DOI: 10.1371/journal.pbio.2000016. View

2.
Kastner B, Will C, Stark H, Luhrmann R . Structural Insights into Nuclear pre-mRNA Splicing in Higher Eukaryotes. Cold Spring Harb Perspect Biol. 2019; 11(11). PMC: 6824238. DOI: 10.1101/cshperspect.a032417. View

3.
Henry T, Losordo D, Traverse J, Schatz R, Jolicoeur E, Schaer G . Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials. Eur Heart J. 2018; 39(23):2208-2216. DOI: 10.1093/eurheartj/ehx764. View

4.
Haendeler J, Hoffmann J, Brandes R, Zeiher A, Dimmeler S . Hydrogen peroxide triggers nuclear export of telomerase reverse transcriptase via Src kinase family-dependent phosphorylation of tyrosine 707. Mol Cell Biol. 2003; 23(13):4598-610. PMC: 164856. DOI: 10.1128/MCB.23.13.4598-4610.2003. View

5.
Ulaner G, Hu J, Vu T, Giudice L, Hoffman A . Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res. 1998; 58(18):4168-72. View